The Biotechnology and Biological Sciences Research Council (BBSRC), Engineering and Physical Science Research Council (EPSRC) and Medical Research Council (MRC) have established five interdisciplinary and complementary research Hubs as part of a £25M UK Regenerative Medicine Platform (UKRMP).
Theme 5: Immunomodulation Hub
The UKRMP will address the technical and scientific challenges associated with translating promising scientific discoveries in this area towards clinical impact. Together the Hubs provide a world-leading programme to promote the development of regenerative therapies. Each of the Hubs provides a UK centre of expertise/knowledge with the necessary critical mass to address key translational challenges and provide new tools, protocols and resources with broad applicability that can be utilised by other UK research groups in academia and industry.
The Hubs provide a cornerstone of the broader UK research strategy in this area, which is seeking to support high quality UK research activity and translational activity that will help deliver the great promise of regenerative medicine to the benefit of both patients and future economic growth. More information on the Hubs can be found here.
Monday, October 13, 2014
The MHRA and HTA have announced a new ‘One stop shop’ regulatory advice service for regenerative medicine. This follows as […]More »
Monday, August 4, 2014
Date: 17 Sep 2014 09:00 – 18:00 Venue: The University of Leeds A one day meeting focused solely on the translation […]More »
Tuesday, July 29, 2014
The MRC and the Department of Biotechnology (DBT), Government of India invite proposals to the UK-India Joint Centre Partnerships call. This […]More »